AnaptysBio Inc News - ANAB | ADVFN

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

AnaptysBio Inc (ANAB)

37.06

-0.17

(-0.46%)

Closed July 27 4:00PM

Delayed by 15 minutes

36.99

-0.07

(-0.19%)

After Hours: 7:59PM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Redwire Corporation to Report Second Quarter 2024 Results on August 7, 2024

Redwire Corporation (NYSE: RDW; “Redwire” or “the Company”) today announced that it will report financial results for the second quarter ended...

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Redwire Secures Follow-On Order for Roll-Out Solar Arrays for Thales Alenia Space’s Newest Telecommunications Satellite Product Line

Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, today announced it has secured a...

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Phase Four Partners with Redwire to Expand Space Propulsion Offerings and Deliver Hall Effect Thrusters

Phase Four Partners with Redwire to Expand Space Propulsion Offerings and Deliver Hall Effect Thrusters PR...

Redwire Developing Advanced Thruster Technology to Offer Reliable, High-Volume Production to Support DoD Small Satellite Supply Chain

Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today it has signed a...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

1
Next

gfp927z

gfp927z 2 years ago

HighPeaks, The NY Times article was high profile, but the connection to ANAB isn't readily apparent.

Even with the partial sale/monetization of the revenue stream from dostarlimab in December, the drug is also being studied by Glaxo for other cancer types (endometrial, non-small cell lung, ovarian, and mismatch repair deficient solid tumors). One question to answer is whether the monetization deal with Sagard was only for colorectal, or for all the indications? Probably for all, but I'll have to do more research.

ANAB has numerous other programs and a large pile of cash, so looks interesting. But investing in biotech requires a ton of research, but even then you still don't know what you have, and landmines are everywhere. Better to invest in 'what you know', as Buffett recommends :o)

---

HighPeaks

HighPeaks 2 years ago

Thanks TP. Yeah this has the potential to really be a big mover. So surprised no one has made the connection between this potential miracle drug and $ANAB receiving royalties on it(as it’s originator). GSK is the collaborator who has just commercialized it but it’s ANAB invention.

tedpeele

tedpeele 2 years ago

Tremendous find HighPeaks. .You have been early on quite a few big movers. I'm thinking this is yet another one.

Will be watching this closely...thanks.

HighPeaks

HighPeaks 2 years ago

According to this link ANAB gets 8-25% royalties from Dostarlimab. This drug has recently shown phenomenal results in a trial at Memorial Sloan Kettering Hospital. All patients fully recovered from rectal cancer.
https://www.globenewswire.com/fr/news-release/2020/10/26/2114250/0/en/AnaptysBio-and-GlaxoSmithKline-Amend-Strategic-Immuno-Oncology-Collaboration.html

TFMG

TFMG 4 years ago

$ANAB | #Anaptysbio Spikes After Drug Designation

Nice spike in the afterhours session, lets hope we
can get some continuation tomorrow.
Target $29.00 to Fib Golden Pocket
Also a very large gap to fill at $35.00
AnaptysBio gets orphan drug designation of imsidolimab for pustular psoriasis
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.

LoveItInBishop

LoveItInBishop 5 years ago

RSI @ 16. laughable. Zacks has positive take. https://finance.yahoo.com/news/anaptysbio-enters-oversold-territory-135501475.html

ClayTrader

ClayTrader 5 years ago

* * $ANAB Video Chart 11-13-19 * *

Link to Video - click here to watch the technical chart video

ClayTrader

ClayTrader 5 years ago

* * $ANAB Video Chart 11-08-19 * *

Link to Video - click here to watch the technical chart video

waterchaser

waterchaser 5 years ago

LOL! Twitter PnD. Buyer beware.

420man

420man 5 years ago

Once the real bounce starts it will be fast....

Crazy Money

Crazy Money 5 years ago

420man

420man 5 years ago

This will bounce..... 15 AH

RJ Trotts

RJ Trotts 5 years ago

trying to bounce back over $11, hoping for more

TaxiCaT

TaxiCaT 5 years ago

celle

celle 5 years ago

Nothing happen here?

manny371

manny371 7 years ago

This stock is making noise! Bought in Sept $ANAB

PyroGenesis Canada

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions